{"id":142717,"date":"2023-02-24T06:39:35","date_gmt":"2023-02-24T11:39:35","guid":{"rendered":"https:\/\/44.250.171.167\/?p=142717"},"modified":"2023-02-24T06:39:37","modified_gmt":"2023-02-24T11:39:37","slug":"earnings-brooks-laboratories-ltd-nse-brooks-q3fy23-results-out-total-income-fell-20-yoy","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-brooks-laboratories-ltd-nse-brooks-q3fy23-results-out-total-income-fell-20-yoy\/","title":{"rendered":"Earnings | Brooks Laboratories Ltd (NSE: BROOKS): Q3FY23 Results Out; Total Income fell 20% YoY"},"content":{"rendered":"\n<p><a href=\"https:\/\/44.250.171.167\/symbol\/brooks\/\">Brooks Laboratories Ltd (NSE: BROOKS)<\/a> is a pharmaceutical company based in India. The company offers a range of products that include dry powder injections, liquid injections, carbapenem dry power injectables, tablets, and oral suspensions. These products are used in different therapeutic segments, such as anti-bacterial, antibiotics, anti-gastric, anti-malarial, and life-saving drugs. The company&#8217;s product portfolio is diverse and caters to a wide range of medical needs, allowing it to serve a large customer base. By offering products in different forms and therapeutic segments, Brooks Laboratories can appeal to a broad range of healthcare professionals and patients.<\/p>\n\n\n\n<p>In December 2022, Brooks Laboratories Ltd reported a total income of Rs. 15.30 crore, a decrease of 15.49% compared to the same period in the previous year. The total expenses during this period were Rs. 23.85 crore, which is a decrease of 0.27% compared to the same period in the previous year. The company reported an EBIT (earnings before interest and taxes) of -Rs. 8.55 crore in December 2022. This means the company incurred a loss before considering the impact of interest and taxes. There is no growth rate mentioned for EBIT in the given data. The net profit after tax (PAT) for the company was -Rs. 9.48 crore in December 2022, indicating a loss. The company had reported a PAT of -Rs. 7.40 crore in the same period the previous year. <\/p>\n\n\n\n<p>The EBIT margin in December 2022 was -67.78%, indicating that the company&#8217;s operating expenses exceeded its operating income during the period. The net profit margin was -61.59%, indicating that the company incurred a net loss. The basic earnings per share (EPS) for the company in December 2022 was -Rs. 2.03. This means that for every share of the company, the loss per share was Rs. 2.03 in December 2022.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Brooks Laboratories Ltd (NSE: BROOKS) is a pharmaceutical company based in India. The company offers a range of products that include dry powder injections, liquid injections, carbapenem dry power injectables, tablets, and oral suspensions. These products are used in different therapeutic segments, such as anti-bacterial, antibiotics, anti-gastric, anti-malarial, and life-saving drugs. The company&#8217;s product portfolio [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,5747],"tags":[1115],"class_list":["post-142717","post","type-post","status-publish","format-standard","hentry","category-earnings","category-healthcare-stocks","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":141613,"url":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-nse-brooks-ltd-q3-fy23-results-out-total-income-fell-20-yoy\/","url_meta":{"origin":142717,"position":0},"title":"Brooks Laboratories Ltd.(NSE: BROOKS) Ltd. : Q3 FY23 Results Out; Total Income fell 20% YoY","author":"Divyansh_Kasana","date":"February 14, 2023","format":false,"excerpt":"Brooks Laboratories Limited (NSE: BROOKS) is a pharmaceutical contract research and manufacturing services company based in India. It offers a range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and Tablets.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":143944,"url":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-revolutionizes-healthcare-industry-with-groundbreaking-research-and-innovation\/","url_meta":{"origin":142717,"position":1},"title":"Brooks Laboratories Ltd. Revolutionizes Healthcare Industry with Groundbreaking Research and Innovation!","author":"Divyansh_Kasana","date":"April 21, 2023","format":false,"excerpt":"Stock Data: TickerNSE: BROOKS & BSE:\u00a0533543ExchangeNSE & BSEIndustryPHARMACEUTICALS & BIOTECHNOLOGY Price Performance: Last 5 Days-1.49%YTD-39.27%Last 12 Months-33.95% Company Description: Brooks Laboratories Ltd is a contract-based pharmaceutical manufacturing company with a diversified product portfolio that includes dry powder injections, liquid injections, carbapenem dry power injectables, tablets, and oral suspensions used in\u2026","rel":"","context":"In &quot;Research Summary&quot;","block_context":{"text":"Research Summary","link":"https:\/\/alphastreet.com\/india\/category\/research-summary\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":147882,"url":"https:\/\/alphastreet.com\/india\/alphagraph-brooks-laboratories-ltd-nse-brooks-q4fy23-results-out-total-income-fell-56-yoy\/","url_meta":{"origin":142717,"position":2},"title":"Alphagraph | Brooks Laboratories Ltd (NSE: BROOKS): Q4FY23 Results Out; Total Income fell 56% YoY.","author":"Divyansh_Kasana","date":"May 31, 2023","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical manufacturing company that primarily operates on a contract basis. The company specializes in the production of pharmaceutical products on behalf of other companies. As a contract manufacturer, Brooks Laboratories works closely with its clients to manufacture pharmaceuticals based on their specific requirements and formulations.\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152487,"url":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-q1fy24-8-fall-in-revenue\/","url_meta":{"origin":142717,"position":3},"title":"Brooks Laboratories Ltd Q1FY24; 8% fall in Revenue","author":"Divyansh_Kasana","date":"August 10, 2023","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical manufacturing company primarily working on contract basis. Financial Results: Brooks Laboratories Ltd reported Revenues for Q1FY24 of \u20b915.70 Crores down from \u20b917.12 Crore year on year, a fall of 8.29%. Total Expenses for Q1FY24 of \u20b920.22 Crores down from \u20b928.32 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":136984,"url":"https:\/\/alphastreet.com\/india\/everything-you-need-to-know-about-brooks-laboratories-limitednsebrooks-stock-up-30-in-2-months\/","url_meta":{"origin":142717,"position":4},"title":"Everything You Need to Know About Brooks Laboratories Limited(NSE:BROOKS)| Stock UP 30% in 2 Months","author":"Divyansh_Kasana","date":"November 20, 2022","format":false,"excerpt":"Brooks Laboratories Limited(NSE:BROOKS) has an industry presence of nearly two decades now, leading to established relationships with the customers as well as suppliers. The company is engaged in the manufacturing of pharmaceutical formulations and is supplying to various reputed players.\u00a0 Brooks Laboratories Limited(NSE:BROOKS) has floated a Joint Venture (JV) named\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/Galaxy.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/Galaxy.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/Galaxy.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/Galaxy.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":136955,"url":"https:\/\/alphastreet.com\/india\/infographic-brooks-labrotories-nse-brooks-q2-results-released-revenue-down-15-74-yoy\/","url_meta":{"origin":142717,"position":5},"title":"Infographic : Brooks Labrotories (NSE : BROOKS) | Q2 Results Released! | Revenue DOWN 15.74% YoY","author":"Divyansh_Kasana","date":"November 18, 2022","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both units are cGMP compliant in accordance with national and international standards. The Vadodara facility has been approved by the European Medicines Agency. The company has a wide range\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=142717"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142717\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=142717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=142717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=142717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}